Total Funding
94
72
Total FundingDebt Financing raised
Growth Score 94 in past quarter
3 pts
Heat Score 72 in past quarter
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
23962
Minapharm Pharmaceuticals is operates as a pharmaceutical company primarily in Egypt and the Middle East.
- Wafik Bardissi: Chief Executive Officer & Chairman
- Dr. Saad El Bardissi: Founder
About the Company
MINAPHARM is constantly striving to provide innovative quality medicines and services to patients in developing countries so they, too, can get a timely benefit from the latest advances in pharmaceutical and biopharmaceutical research technologies. To achieve its mission and strategic goals, MINAPHARM exploits a robust research and development
platform combined with strategic multi-alliances involving industry players at the forefront of the latest pharmaceutical technologies, marketing and management techniques. This way has further enabled the establishment of specialized lines, embracing innovative and affordable products and services in the fields of Gastroenterology, Cardiology, Ophthalmology, Orthopedics, and Uro-gynaecology.